ADEL-Y01

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameADEL-Y01
Drug Alias NameADEL-Y01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsTauopathiesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOscotec IncADEL Inc
China Registration ClassN/A

Develop Information

Active CompaniesADEL IncSanofiOscotec Inc
Inactive CompaniesAlzheimer's Disease Expert Lab Inc
Active IndicationsTauopathiesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A